Prostate cancer hormone therapy linked with mental decline

02/28/2005 | Forbes

Hormone therapy used to treat prostate cancer can result in significant declines in mental function, according to a small new study. Researchers gave subjects two drugs, flutamide and leuprolid, which reduce production of testosterone and other male hormones that can promote prostate cancer growth, and six months after the therapy was initiated, tests showed significant declines in the patients' visual memory and in recognizing and remembering numbers.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR